EverSource Wealth Advisors LLC Has $543,000 Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

EverSource Wealth Advisors LLC increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 337.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,347 shares of the medical device company’s stock after buying an additional 4,125 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Cooper Companies were worth $543,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Blue Trust Inc. increased its position in Cooper Companies by 54.8% during the 4th quarter. Blue Trust Inc. now owns 96 shares of the medical device company’s stock worth $36,000 after buying an additional 34 shares during the period. Lindbrook Capital LLC increased its position in Cooper Companies by 182.5% during the 4th quarter. Lindbrook Capital LLC now owns 113 shares of the medical device company’s stock worth $43,000 after buying an additional 73 shares during the period. Desjardins Global Asset Management Inc. increased its position in Cooper Companies by 44.8% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 152 shares of the medical device company’s stock worth $58,000 after buying an additional 47 shares during the period. Venturi Wealth Management LLC increased its position in Cooper Companies by 30.4% during the 4th quarter. Venturi Wealth Management LLC now owns 180 shares of the medical device company’s stock worth $68,000 after buying an additional 42 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its position in Cooper Companies by 123.0% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 223 shares of the medical device company’s stock worth $84,000 after buying an additional 123 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on COO. Robert W. Baird raised their price target on Cooper Companies from $116.00 to $118.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Jefferies Financial Group upgraded Cooper Companies from a “hold” rating to a “buy” rating and raised their price target for the stock from $107.00 to $115.00 in a research report on Tuesday, July 16th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, May 31st. Finally, Piper Sandler restated an “overweight” rating and issued a $115.00 price target on shares of Cooper Companies in a research report on Wednesday, July 3rd. Four investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.78.

Cooper Companies Trading Down 1.0 %

Shares of COO stock traded down $0.93 during mid-day trading on Friday, reaching $93.27. 880,304 shares of the stock traded hands, compared to its average volume of 1,253,850. The stock’s fifty day simple moving average is $91.03 and its two-hundred day simple moving average is $94.21. The Cooper Companies, Inc. has a 1-year low of $75.93 and a 1-year high of $104.07. The company has a market cap of $18.57 billion, a price-to-earnings ratio of 54.78, a price-to-earnings-growth ratio of 2.34 and a beta of 0.98. The company has a quick ratio of 1.14, a current ratio of 1.95 and a debt-to-equity ratio of 0.34.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $0.85 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.02. Cooper Companies had a return on equity of 8.87% and a net margin of 9.11%. The company had revenue of $942.60 million during the quarter, compared to the consensus estimate of $948.07 million. During the same period last year, the company earned $0.77 earnings per share. The firm’s revenue was up 7.4% compared to the same quarter last year. On average, research analysts anticipate that The Cooper Companies, Inc. will post 3.57 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.